[PDF][PDF] Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy–a …

S Provatopoulou, D Kalavrizioti, M Stangou… - Romanian Journal of …, 2019 - sciendo.com
Results. Positive anti-PLA2R antibodies at diagnosis were found in 16 of 33 patients
(48.5%). Anti-PLA2R levels were independently associated with the achievement of …

[HTML][HTML] Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience

B Porcelli, A Guarnieri, F Ferretti, G Garosi… - Journal of …, 2021 - Springer
Background Autoantibodies against-phospholipase A2 receptor (PLA2R) are specific
markers of idiopathic membranous nephropathy (iMN). Enzyme-linked immunosorbent …

Antibodies against M-type phospholipase A2 receptor may predict treatment response and outcome in membranous nephropathy

Z Qu, M Zhang, Z Cui, J Wang, M Wang… - American Journal of …, 2018 - karger.com
Background: Anti-phospholipase A2 receptor (PLA2R) antibodies are specific to the
diagnosis of primary membranous nephropathy (pMN). The prevalence of positive …

Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy

LM Rodas, A Matas-García, X Barros… - Clinical Kidney …, 2019 - academic.oup.com
Background M-type phospholipase A2 receptor (APLA2R) is considered the major antigen
involved in the pathogenesis of adult primary membranous nephropathy (MN), which is the …

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy

G Stefan, S Stancu, A Zugravu, O Popa, D Zubidat… - Renal …, 2022 - Taylor & Francis
Background The value of anti-phospholipase A2 receptor antibody (anti-PLA2R ab)
monitoring at 3 months after diagnosis in membranous nephropathy (MN) remains …

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Y Katsumata, Y Okamoto, T Moriyama… - Immunological …, 2020 - Taylor & Francis
Associations between anti-M-type phospholipase A2 receptor (PLA2R) antibodies and
disease activity and prognosis have been suggested in primary membranous nephropathy …

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy

P Jullien, B Seitz Polski, N Maillard… - Clinical kidney …, 2017 - academic.oup.com
Background: The diagnostic role of circulating anti-phospholipase A2 receptor antibodies
(anti-PLA2R Abs) is now well recognized in idiopathic membranous nephropathy (iMN) …

Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy

M Tampoia, F Migliucci, C Villani, L Abbracciavento… - Journal of …, 2018 - Springer
Autoantibodies against phospholipase A2 receptor (PLA2R) are a sensitive and specific
marker for idiopathic membranous nephropathy (IMN). The aim of our study was to redefine …

[HTML][HTML] Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous …

D Dong, T Fan, Y Wang, L Zhang, L Song, L Zhang - BMC nephrology, 2019 - Springer
Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)

A Radice, B Trezzi, U Maggiore, F Pregnolato… - Autoimmunity …, 2016 - Elsevier
Autoantibodies to M-type phospholipase A2 receptor (PLA2R) are specific markers of
idiopathic membranous nephropathy (IMN). They can differentiate IMN from other …